Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2018-02-23 2018-02-09
Drug Identification Number 02401967 02401967
Brand name TRICIRA LO TRICIRA LO
Common or Proper name NORGESTIMATE/ETHINYL ESTRADIOL NORGESTIMATE/ETHINYL ESTRADIOL
Company Name APOTEX INC APOTEX INC
Ingredients ETHINYL ESTRADIOL ETHINYL ESTRADIOL ETHINYL ESTRADIOL NORGESTIMATE NORGESTIMATE NORGESTIMATE ETHINYL ESTRADIOL ETHINYL ESTRADIOL ETHINYL ESTRADIOL NORGESTIMATE NORGESTIMATE NORGESTIMATE
Strength(s) 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 21 BLS 21 BLS
ATC code G03AB G03AB
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-15 2018-01-15
Estimated end date 2018-03-09 2018-03-09
Actual end date 2018-02-19
Shortage status Resolved Actual shortage
Company comments
Health Canada comments